The Latest Breaking News from AstraZeneca

Chancellor hopes to cut state aid for Speke vaccine plant to £40m. But pro-growth Treasury must not let project slip overseas

Chancellor reportedly seeking to cut £20m from the £65m promised by Hunt to Merseyside manufacturing plant

A renaissance is stirring in cholesterol treatment, and it could drive Merck, Novartis and other stocks higher, while delivering new choices for millions of patients.

There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.

These five companies may offer higher earnings and return potential with lower risk. Two Leaderboard stocks included.

The annual conference of the American Society of Clinical Oncology is always the biggest event-making cancer conference. And this year, the attention-grabber was AstraZeneca, as its lung and breast cancer drugs significantly slowed the spread of disease in two trials, potentially establishing the medicines as the new standard of care…

The share price recovery has been partly driven by the surge in wholesale energy prices, which is beyond his control

Women with HER2-low incurable secondary disease in Scotland currently have access, while others across the UK do not

The former pharma laggard is in a race with Shell to be the first FTSE 100 stock to be valued at £200bn